Shield Therapeutics plc (STX) — Capital Reinvestment Ratio

Latest as of June 2020: 0.00x

Shield Therapeutics plc (STX) has a Capital Reinvestment Ratio of 0.00x as of June 2020, meaning it reinvests 0% of its operating cash flow (GBX2.40 Million) in capital expenditures (GBX2.00K). See STX equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

GBX2.40 Million

GBX

Capital Expenditures

GBX2.00K

GBX

Data as of

Jun 2020

Most recent filing

Annual Capital Reinvestment Ratio for Shield Therapeutics plc (None–None)

Year-by-year Capital Reinvestment Ratio for Shield Therapeutics plc from None to None. For live market cap and broader valuation context, see Shield Therapeutics plc stock valuation.

Year	Reinvestment Ratio	Operating CF (GBX)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow